Zimbabwe has turned down a substantial American health deal valued at 367 million US dollars (272 million pounds) over five years over Washington's request for sensitive data.
The decision was revealed after a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official spokesperson has since stated that the United States was demanding access to genetic material for scientific study and profit but was not willing to guarantee the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for continued negotiations to find a deal agreeable to all parties so the country's vital HIV programme can continue.
Wider Implications
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court halted a related health funding agreement after legal challenges were filed about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.
As per reports, Sixteen nations in Africa have so far signed these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to share its biological resources and data for a long time, without any equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," Mangwana explained.
"Put simply, our country would supply the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our citizens should a future health crisis emerge."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were disrupting structures previously set up via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.
"This framework is intended to guarantee that when a nation provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the capability to create them."
These objections regarding the US deal "are not meant as anti-American sentiment," he added.
"We encourage continued dialogue with our American counterparts on how future collaboration could be designed in a way that honours the independence and dignity of both nations."
Medical Community Response
A leading public health body expressed it recognised the government's concerns, but recommended that talks need to persist given that much of the country's Aids initiatives relied on foreign aid.
"If technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," the group added.
The halted deal underscores the complex tensions between receiving vital international aid and protecting local interests in an increasingly interconnected world.